Please login to the form below

Not currently logged in
Email:
Password:

Ferring Pharmaceuticals

This page shows the latest Ferring Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Ferring agrees Chinese reproductive medicine research deal

Ferring agrees Chinese reproductive medicine research deal

Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) are set to collaborate on a long-term project to advance basic and translational research in reproductive medicine. ... Per Falk, executive vice president and chief scientific officer of

Latest news

  • SMC gives green light for Amgen’s Kyprolis SMC gives green light for Amgen’s Kyprolis

    Ferring Pharmaceutical’s idiopathic nocturnal polyuria drug Noqdirna (desmopressin oral lypohilisate) also received a green light, however Biofrontera’s Ameluz (aminolaevulinic acid hydrochloride) wasn’t as lucky as the committee said

  • Ferring signs telemedicine collaboration with Danish hospital Ferring signs telemedicine collaboration with Danish hospital

    Ferring Pharmaceuticals has signed a telemedicine deal with a Copenhagen hospital that it hopes will transform patient care in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). ... The Swiss firm will collaborate with North Zealand

  • Golden night for Saatchi & Saatchi at the PM Society Awards Golden night for Saatchi & Saatchi at the PM Society Awards

    views.” . Teva Pharmaceuticals and Allergan shared top honours in the Gold category, taking home two apiece, with AstraZeneca, Shire and Gilead among those picking up a single Gold at the awards. . ... Craft Award for Disease Awareness - McCann

  • Ferring collaborates on novel IBD drug development Ferring collaborates on novel IBD drug development

    Project in partnership with Paris-based Institut Pasteur.  . Ferring Pharmaceuticals and non-profit biomedical research centre the Institut Pasteur are to collaborate on drug development for patients with inflammatory bowel disease ... Per Falk,

  • TxCell plans listing as EU biotech wakes up to IPOs

    The Valbonne-based specialist in personalised cell therapies announced its intention to float at the same time as it unveiled a 76m ($108m) deal giving Ferring Pharmaceuticals an exclusive option to ... Ferring is paying 3m upfront for rights to Ovasave,

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Interview: Michel Pettigrew, Ferring Interview: Michel Pettigrew, Ferring

    Ferring Pharmaceuticals' president on how the company encourages 'controlled entrepreneurship'. Before Michel Pettigrew took the reins at Ferring Pharmaceuticals more than a decade ago he admits he didn't know much ... Single-minded pursuit of progress.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • IFPMA names new communications director IFPMA names new communications director

    Helen Gallagher joins the association from Ferring Pharmaceuticals. IFPMA has appointed Helen Gallagher as  its new communications director, a role that will see her act as a key spokesperson for the ... Prior to her new role at IFPMA, Gallagher headed

  • Ferring appoints executive VP and chief medical officer Ferring appoints executive VP and chief medical officer

    Professor Klaus Dugi joins the pharma group from Boehringer Ingelheim. Ferring Pharmaceuticals has appointed professor Klaus Dugi as its executive vice president and chief medical officer; roles that will see him ... Michel Pettigrew, president of the

  • Ferring promotes Lars Peter Brunse to chief production officer Ferring promotes Lars Peter Brunse to chief production officer

    He also joins the Swiss pharma firm's executive board. Saint-Prex, Switzerland-based Ferring Pharmaceuticals has appointed Lars Peter Brunse as its vice president and chief production officer, roles that ... Michel Pettigrew, president of the executive

  • Paul Navarre moves from Allergan to Ferring Pharmaceuticals Paul Navarre moves from Allergan to Ferring Pharmaceuticals

    Takes up CEO role at its Ferring Holding subsidiary. Ferring Pharmaceuticals has appointed Paul Navarre as CEO of Ferring Holding Inc - a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharma ... He said: “ Ferring is a fast

  • Ferring Pharmaceuticals promotes Aaron Graff Ferring Pharmaceuticals promotes Aaron Graff

    Swiss biopharmaceutical company Ferring Pharmaceuticals has promoted Aaron Graff to chief commercial officer and executive vice president. ... Michel Pettigrew, president of Ferring Pharmaceuticals’ executive board and chief operating officer, said:

More from appointments
Approximately 5 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • IGNIFI

    Allergan . Biogen . Boehringer Ingelheim . Danone Nutricia . Ferring Pharmaceuticals . MSD Healthcare Services .

  • Packer Forbes News February 2016

    The picture shows Packer Forbes’ CEO, Alexa Forbes, and host, Jack Whitehall presenting the winners’ trophy to Lime and Ferring Pharmaceuticals for their work in the field of growth hormone deficiency.

  • Lucid Group Communications Limited

    Celgene. CSL Behring. Eisai. Ferring Pharmaceuticals Ltd. Genzyme. Gilead. GlaxoSmithKline. Janssen.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics